InvestorsHub Logo
Post# of 252423
Next 10
Followers 29
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

Re: DewDiligence post# 92053

Wednesday, 03/10/2010 3:23:44 AM

Wednesday, March 10, 2010 3:23:44 AM

Post# of 252423
Being a consultant for BMY didn't stop Prof. Eggermont from stressing the autoimmune toxicities of anti-CTLA4 agents (and the danger to patients with clinical or subclinical autoimmune disease), at the 11th World Congress on Cancers of the Skin. Btw, he was the lead investigator of the EORTC's ganglioside GM2-KLH vaccine failed (has been halted early) trial in melanoma.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.